Biotechnology company
Issues pertaining to cancer screening H.R. 1946 and S. 1873 (Medicare Multi-Cancer Early Detection Screening Coverage Act of 2021), all provisions H.R. 6000 (Cures 2.0 Act), all provisions S. 4348 (FDASLA Act of 2022), Title VIII, Subtitle C, regarding regulation of in vitro clinical tests H.R. 7667 (Food and Drug Amendments of 2022), all provisions
HCR - Health Issues
2 - HOUSE OF REPRESENTATIVES 1 - SENATE
ARENTFOX SCHIFF LLP
1717 K Street, NW, Washington, DC, 20006, US
DAN RENBERG